Publications: all consultations

You can use the filters to show only results that match your interests

Filter publications
36 publications by Medicines and Healthcare products Regulatory Agency ×
Get updates to this list email feed

Copy and paste this URL in to your feed reader

  1. Implementing ‘safety features’ under the Falsified Medicines Directive

    • MHRA
    • Open consultation
  2. Health institution exemption for IVDR/MDR

    • MHRA
    • Open consultation
  3. Post-implementation Review of the Human Medicines Regulations 2012 (MLX 391)

    • MHRA
    • Consultation outcome
  4. Proposal to make Sildenafil 50mg film-coated tablets available from Pharmacies

    • MHRA
    • Consultation outcome
  5. Strategy for pharmacopoeial public quality standards for biological medicines

    • MHRA
    • Consultation outcome
  6. Proposal to make Dovonex Psoriasis Ointment available from Pharmacies

    • MHRA
    • Consultation outcome
  7. Proposal to make Arthriex 750mg and 1500mg film-coated tablets available from Pharmacies

    • MHRA
    • Consultation outcome
  8. Classification of Nasonex Allergy Control Nasal Spray

    • MHRA
    • Consultation outcome
  9. Reclassification of Otrivine extra dual relief nasal spray solution (ARM 90)

    • MHRA
    • Consultation outcome
  10. Proposal to make Maloff Protect 250mg/100mg film-coated tablets available from Pharmacies

    • MHRA
    • Consultation outcome
  11. Proposal on increases and additions to current medical devices fees

    • MHRA
    • Consultation outcome
  12. Pharmacy dispensing models and displaying prices on medicines

    • DHSC and MHRA
    • Closed consultation
  13. Regulatory fees for e-cigarettes

    • MHRA
    • Consultation outcome
  14. Classification of Ibuprofen Seven Plus 200mg/5ml Oral Suspension

    • MHRA
    • Closed consultation
  15. Regulatory fees for medicines: 2016 to 2017 and fees for online sellers of medicines

    • MHRA
    • Consultation outcome
  16. Proposal to allow wider access to naloxone for use in emergencies

    • MHRA
    • Closed consultation
  17. British Pharmacopoeia Commission: triennial review

    • DHSC and MHRA
    • Consultation outcome

    First published during the 2010 to 2015 Conservative and Liberal Democrat coalition government

  18. Commission on Human Medicines: triennial review

    • DHSC, MHRA and CHM
    • Consultation outcome

    First published during the 2010 to 2015 Conservative and Liberal Democrat coalition government

  19. Hormonal pregnancy tests: call for evidence

    • MHRA
    • Closed consultation
  20. Classification of Nexium Control 20mg Gastro-Resistant

    • MHRA
    • Consultation outcome
  21. Allowing paramedics involved in helicopter search and rescue operations to administer medicines

    • MHRA
    • Closed consultation
  22. Amendments to the Human Medicines Regulations 2012

    • DHSC and MHRA
    • Consultation outcome

    First published during the 2010 to 2015 Conservative and Liberal Democrat coalition government

  23. Reclassify Soleve Sunburn Relief cutaneous emulsion

    • MHRA
    • Closed consultation
  24. Transfer of responsibility of the certificate of free sales (CFS) to MHRA

    • MHRA
    • Consultation outcome
  25. Proposal to simplify the information requirements for advertising of medicinal products to prescribers and suppliers of medicines (MLX384)

    • MHRA
    • Consultation outcome
  26. Supplying asthma inhalers to schools for emergency use

    • DHSC and MHRA
    • Consultation outcome

    First published during the 2010 to 2015 Conservative and Liberal Democrat coalition government

  27. Safety feature (Falsified Medicines Directive): ‘black’ and ‘white’ lists

    • MHRA
    • Closed consultation
  28. Plans to revoke ‘The Clinical Thermometers Regulations 1993’

    • MHRA
    • Closed consultation
  29. MHRA business engagement assessment - variations processing review

    • MHRA
    • Consultation outcome
  30. Change in classification of Galpharm Period Pain Relief 250mg Gastro-Resistant Tablets (ARM 87)

    • MHRA
    • Closed consultation
  31. Change in legal classification of Nurofen Express 400mg Oral Powder (ARM 86)

    • MHRA
    • Closed consultation
  32. MHRA business engagement assessment on introduction of tell-and-do variations for a specific subset of parallel import licences

    • MHRA
    • Closed consultation
  33. Availability of diclofenac as a pharmacy medicine (MLX 382)

    • MHRA
    • Closed consultation
  34. European Commission's proposal for pharmacovigilance fees payable to the European Medicines Agency

    • DHSC and MHRA
    • Closed consultation

    First published during the 2010 to 2015 Conservative and Liberal Democrat coalition government

  35. Proposal to end sell-through period for unlicensed herbal medicines

    • MHRA
    • Consultation outcome
  36. Classification of Pirinase Hayfever Relief for Adults 0.05% Nasal Spray

    • MHRA
    • Consultation outcome